 |
Market Cap | 2.27B | EPS (ttm) | 1.44 |
P/E | 15.65 | EPS this Y | 37.86% |
Forward P/E | 12.10 | EPS next Y | 18.59% |
PEG | 0.57 | EPS past 5Y | - |
P/S | 0.85 | EPS next 5Y | 27.68% |
P/B | 3.18 | EPS Q/Q | 26.25% |
Dividend | - | Sales Q/Q | 8.99% |
Insider Own | 1.88% | Inst Own | 100.19% |
Insider Trans | -0.11% | Inst Trans | -0.56% |
Short Float | 4.24% | Earnings | Apr 23/a |
Analyst Recom | 3.40 | Target Price | 23.00 |
Avg Volume | 904.72K | 52W Range | 18.87 - 30.98 |
|
|
Apr-02-25 | Upgrade |
Pickering Energy Partners |
Underperform → Neutral |
|
|
|
Oceaneering International, Inc. engages in the provision of engineered services and products, and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. It operates through the following business segments: Subsea Robotics, Manufactured Products, Offshore Projects Group (OPG), Integrity Management & Digital Solutions (IMDS), and Aerospace and Defense Technologies (ADTech). The Subsea Robotics segment includes remotely operated vehicles, survey services, and ROV tooling businesses. The Manufactured Products segment provides distribution systems, such as production control umbilicals and connection systems made up of specialty subsea hardware, and provides turnkey solutions that include project management, engineering design, fabrication/assembly, and installation of autonomous mobile robotic technology to industrial, manufacturing, healthcare, warehousing, and commercial theme park markets. The OPG segment focuses on subsea project capabilities and solutions. The IMDS segment covers asset integrity management, corrosion management, inspection, and nondestructive testing services. The ADTech segment provides government services and products, including engineering related manufacturing in defense and space exploration activities. The company was founded in 1969 and is headquartered in Houston, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GRANATO LEONARDO P | SVP, IMDS | Nov 07 '24 | Sale | 28.12 | 2,000 | 56,240 | 19,860 | Nov 12 04:22 PM | GRANATO LEONARDO P | Officer | Nov 07 '24 | Proposed Sale | 28.12 | 2,000 | 56,240 | | Nov 07 10:22 AM | Beachy Karen H | Director | Sep 10 '24 | Sale | 22.94 | 3,300 | 75,702 | 28,229 | Sep 11 05:13 PM | Beachy Karen H | Director | Sep 10 '24 | Proposed Sale | 22.94 | 3,300 | 75,702 | | Sep 10 10:36 AM | MCEVOY M KEVIN | Director | Aug 20 '24 | Sale | 26.12 | 9,675 | 252,711 | 141,837 | Aug 21 06:09 PM |
|
|
 |
 |
Market Cap | 13.20B | EPS (ttm) | 10.70 |
P/E | 18.68 | EPS this Y | 14.23% |
Forward P/E | 7.92 | EPS next Y | 10.13% |
PEG | 1.64 | EPS past 5Y | -5.04% |
P/S | 0.60 | EPS next 5Y | 11.38% |
P/B | 1.22 | EPS Q/Q | -6.69% |
Dividend | 1.84% | Sales Q/Q | 5.94% |
Insider Own | 0.49% | Inst Own | 97.44% |
Insider Trans | 0.00% | Inst Trans | 1.93% |
Short Float | 0.93% | Earnings | Feb 06/a |
Analyst Recom | 1.43 | Target Price | 250.75 |
Avg Volume | 510.26K | 52W Range | 178.84 - 233.81 |
|
|
Apr-02-25 | Upgrade |
JP Morgan |
Neutral → Overweight |
$237 |
Apr-02-25 | Downgrade |
UBS |
Buy → Neutral |
$216 |
|
|
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. It operates through the following segments: U.S. and Latin America, Canada, Europe, Middle East, and Africa, Asia Pacific, and Corporate and Other. The U.S. and Latin America segment markets individual and group life and health reinsurance to domestic clients for a variety of products through yearly renewable term agreements, coinsurance, and modified coinsurance. The Canada segment offers individual life reinsurance, and, to a lesser extent, creditor, group life and health, critical illness, and disability reinsurance, through yearly renewable term and coinsurance agreements. The Europe, Middle East, and Africa segment serves individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage that provides a benefit in the event of the diagnosis of a pre-defined critical illness, and underwritten annuities. The Asia Pacific segment consists of individual and group life and health reinsurance, critical illness coverage, disability, and superannuation through yearly renewable term and coinsurance agreements. The Corporate and Other segment consists of investment income from unallocated invested assets, investment related gains, and losses and service fees. The company was founded in 1973 and is headquartered in Chesterfield, MO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
LARSON TODD C | Former Officer | Mar 20 '25 | Proposed Sale | 191.64 | 7,698 | 1,475,234 | | Mar 20 04:21 PM | CHENG TONY KIN SHUN | President and CEO | Dec 18 '24 | Option Exercise | 90.06 | 3,411 | 307,195 | 25,490 | Dec 20 01:20 PM | Wainwright Simon | EVP, Head of EMEA | Dec 17 '24 | Option Exercise | 90.06 | 2,370 | 213,442 | 11,174 | Dec 19 01:00 PM | HUTTON WILLIAM L | EVP, General Counsel & Secy. | Sep 19 '24 | Option Exercise | 138.31 | 2,166 | 299,586 | 13,955 | Sep 23 04:19 PM | HUTTON WILLIAM L | EVP, General Counsel & Secy. | Sep 23 '24 | Sale | 218.97 | 1,209 | 264,735 | 12,357 | Sep 23 04:19 PM |
|
|
 |
 |
Market Cap | 27.71B | EPS (ttm) | 0.17 |
P/E | 82.35 | EPS this Y | 99.29% |
Forward P/E | 17.76 | EPS next Y | 70.24% |
PEG | 1.22 | EPS past 5Y | - |
P/S | 5.94 | EPS next 5Y | 67.23% |
P/B | 2.88 | EPS Q/Q | 358.91% |
Dividend | 1.15% | Sales Q/Q | 25.28% |
Insider Own | 9.00% | Inst Own | 70.42% |
Insider Trans | 0.00% | Inst Trans | 0.48% |
Short Float | 22.79% | Earnings | Feb 27/a |
Analyst Recom | 3.00 | Target Price | 14.05 |
Avg Volume | 6.29M | 52W Range | 9.52 - 20.23 |
|
|
Apr-02-25 | Upgrade |
Keefe Bruyette |
Underperform → Mkt Perform |
$14 |
Apr-02-25 | Upgrade |
Deutsche Bank |
Hold → Buy |
$16 |
|
|
Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rizik Matthew | Director | Jun 28 '24 | Buy | 13.79 | 318 | 4,385 | 707,528 | Jun 28 05:00 PM | Rizik Matthew | Director | Jun 27 '24 | Buy | 13.80 | 316 | 4,361 | 707,210 | Jun 28 05:00 PM | Rizik Matthew | Director | Jun 24 '24 | Buy | 14.01 | 310 | 4,343 | 706,418 | Jun 26 06:29 PM | Rizik Matthew | Director | Jun 25 '24 | Buy | 13.81 | 311 | 4,295 | 706,729 | Jun 26 06:29 PM | Rizik Matthew | Director | Jun 26 '24 | Buy | 13.61 | 165 | 2,246 | 706,894 | Jun 26 06:29 PM |
|
|
|  |
 |
Market Cap | 6.06B | EPS (ttm) | 2.38 |
P/E | 26.21 | EPS this Y | 372.03% |
Forward P/E | 4.76 | EPS next Y | 27.39% |
PEG | 0.29 | EPS past 5Y | - |
P/S | 3.19 | EPS next 5Y | 89.37% |
P/B | 3.96 | EPS Q/Q | 272.83% |
Dividend | - | Sales Q/Q | 65.94% |
Insider Own | 6.07% | Inst Own | 91.28% |
Insider Trans | -0.25% | Inst Trans | 3.20% |
Short Float | 5.33% | Earnings | Feb 26/a |
Analyst Recom | 1.43 | Target Price | 166.23 |
Avg Volume | 1.40M | 52W Range | 61.53 - 173.25 |
|
|
Apr-02-25 | Upgrade |
H.C. Wainwright |
Sell → Neutral |
$75 |
|
|
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nicaise Claude | Director | Mar 12 '25 | Option Exercise | 25.18 | 9,746 | 245,404 | 30,303 | Mar 13 08:00 PM | Nicaise Claude | Director | Mar 12 '25 | Sale | 99.64 | 2,491 | 248,203 | 27,812 | Mar 13 08:00 PM | Nicaise Claude | Director | Mar 12 '25 | Proposed Sale | 99.65 | 2,491 | 248,226 | | Mar 12 05:33 PM | Estepan Ian Michael | Chief Financial Officer | Jan 29 '25 | Option Exercise | 12.00 | 15,800 | 189,600 | 49,496 | Jan 31 08:30 PM | Wigzell Hans Lennart Rudolf | Director | Dec 12 '24 | Option Exercise | 13.71 | 10,500 | 143,955 | 33,340 | Dec 16 08:00 PM |
|
|
 |
 |
Market Cap | 3.33B | EPS (ttm) | -0.48 |
P/E | - | EPS this Y | 49.00% |
Forward P/E | 13.62 | EPS next Y | 24.76% |
PEG | - | EPS past 5Y | - |
P/S | 0.94 | EPS next 5Y | 30.23% |
P/B | - | EPS Q/Q | 14.57% |
Dividend | 4.65% | Sales Q/Q | 1.56% |
Insider Own | 24.22% | Inst Own | 74.19% |
Insider Trans | -3.45% | Inst Trans | -2.70% |
Short Float | 9.14% | Earnings | Jan 29/b |
Analyst Recom | 1.70 | Target Price | 74.43 |
Avg Volume | 940.37K | 52W Range | 53.37 - 93.90 |
|
|
Apr-02-25 | Upgrade |
Truist |
Hold → Buy |
$70 |
|
|
Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. Its products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hagedorn Partnership, L.P. | Director | Feb 13 '25 | Sale | 66.70 | 62,877 | 4,194,192 | 13,369,274 | Feb 14 04:38 PM | Sandoval Brian E | Director | Feb 12 '25 | Sale | 65.86 | 1,513 | 99,646 | 13,039 | Feb 13 12:02 PM | Sandoval Brian E | Director | Feb 12 '25 | Proposed Sale | 65.86 | 1,513 | 99,645 | | Feb 12 03:28 PM | Hagedorn Partnership, L.P. | Director | Feb 07 '25 | Sale | 66.86 | 12,123 | 810,544 | 13,432,151 | Feb 11 04:43 PM | Hagedorn Partnership, L.P. | 10% Owner | Feb 07 '25 | Proposed Sale | 66.86 | 75,000 | 5,014,500 | | Feb 07 04:37 PM |
|
|
|  |
 |
Market Cap | 9.60B | EPS (ttm) | 6.97 |
P/E | 13.59 | EPS this Y | -3.54% |
Forward P/E | 10.25 | EPS next Y | 37.42% |
PEG | 0.93 | EPS past 5Y | 5.39% |
P/S | 3.93 | EPS next 5Y | 14.63% |
P/B | 1.23 | EPS Q/Q | 34.45% |
Dividend | 2.30% | Sales Q/Q | 7.88% |
Insider Own | 1.32% | Inst Own | 68.99% |
Insider Trans | -1.08% | Inst Trans | 4.81% |
Short Float | 3.55% | Earnings | Jan 23/a |
Analyst Recom | 1.50 | Target Price | 121.80 |
Avg Volume | 804.56K | 52W Range | 70.68 - 114.26 |
|
|
Apr-02-25 | Upgrade |
Raymond James |
Outperform → Strong Buy |
$120 → $115 |
|
|
SouthState Corp. is a bank and financial holding company, which engages in the provision of banking services and products to customers through its subsidiary. Its services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, mortgage banking services, correspondent banking services and wealth management, and trust services. The company was founded in 1985 and is headquartered in Winter Haven, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Froetscher Janet P | Director | Mar 10 '25 | Buy | 92.02 | 2,717 | 250,018 | 4,689 | Mar 11 04:10 PM | SMITH G STACY | Director | Mar 06 '25 | Buy | 93.60 | 3,100 | 290,160 | 36,779 | Mar 06 04:49 PM | Hobbs Michael B | Officer | Mar 06 '25 | Proposed Sale | 92.69 | 7,399 | 685,813 | | Mar 06 03:36 PM | Williams Douglas Lloyd | President, Atlanta Banking Grp | Mar 01 '25 | Option Exercise | 0.00 | 2,307 | 0 | 21,666 | Mar 04 04:11 PM | ARANA SARA | Chief Accounting Officer | Mar 03 '25 | Sale | 100.78 | 1,991 | 200,653 | 4,787 | Mar 03 05:48 PM |
|
|
 |
 |
Market Cap | 72.50M | EPS (ttm) | -0.88 |
P/E | - | EPS this Y | 24.53% |
Forward P/E | - | EPS next Y | 51.88% |
PEG | - | EPS past 5Y | - |
P/S | 0.06 | EPS next 5Y | - |
P/B | 0.31 | EPS Q/Q | 1.71% |
Dividend | - | Sales Q/Q | -8.10% |
Insider Own | 6.00% | Inst Own | 71.79% |
Insider Trans | 1.87% | Inst Trans | -7.04% |
Short Float | 1.79% | Earnings | Apr 01/a |
Analyst Recom | 1.40 | Target Price | 2.90 |
Avg Volume | 645.24K | 52W Range | 0.92 - 4.44 |
|
|
Apr-02-25 | Upgrade |
Craig Hallum |
Hold → Buy |
$3 |
|
|
Sportsman's Warehouse Holdings, Inc. engages in the retail of sporting and athletic goods. Its products include hunting and shooting, archery, fishing, camping, boating accessories, optics and electronics, knives and tools, and footwear. The company was founded in 1986 and is headquartered in West Jordan, UT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
White Jeffrey Justin | CFO AND SECRETARY | Oct 02 '24 | Buy | 2.30 | 10,000 | 23,000 | 116,326 | Oct 03 04:07 PM | Stone Paul | PRESIDENT AND CEO | Oct 02 '24 | Buy | 2.35 | 31,895 | 74,988 | 936,052 | Oct 03 04:06 PM | MCBEE RICHARD D | Director | Sep 10 '24 | Buy | 2.55 | 20,000 | 51,000 | 205,608 | Sep 10 04:39 PM | Stone Paul | PRESIDENT AND CEO | Sep 09 '24 | Buy | 2.54 | 39,920 | 101,225 | 904,157 | Sep 10 04:38 PM | Bejar Martha Helena | Director | Jun 17 '24 | Sale | 2.67 | 17,000 | 45,373 | 64,997 | Jun 20 04:20 PM |
|
|
|  |
 |
Market Cap | 48.77M | EPS (ttm) | -6.52 |
P/E | - | EPS this Y | 33.91% |
Forward P/E | - | EPS next Y | 39.04% |
PEG | - | EPS past 5Y | -25.38% |
P/S | 0.41 | EPS next 5Y | 38.18% |
P/B | - | EPS Q/Q | 100.73% |
Dividend | - | Sales Q/Q | 4.52% |
Insider Own | 30.26% | Inst Own | 8.65% |
Insider Trans | 62.27% | Inst Trans | -4.02% |
Short Float | 7.12% | Earnings | Mar 18/a |
Analyst Recom | 2.00 | Target Price | 7.62 |
Avg Volume | 311.05K | 52W Range | 0.90 - 6.72 |
|
|
Apr-02-25 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$3.25 |
|
|
Surf Air Mobility, Inc. operates as an electric aviation and air travel company. The company was founded by Sudhin Shahani and Liam Fayed in 2021 and is headquartered in Hawthorne, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Painter Tyler | Director | Mar 26 '25 | Sale | 3.65 | 25,417 | 92,825 | 40,765 | Mar 28 06:34 PM | Palantir Technologies Inc. | 10% Owner | Mar 25 '25 | Buy | 3.88 | 244,011 | 946,763 | 3,421,007 | Mar 27 08:02 PM | ALBERT CARL A | Director | Dec 23 '24 | Buy | 3.47 | 14,500 | 50,315 | 61,928 | Dec 26 07:42 PM | Shahani Sudhin | Director | Dec 23 '24 | Buy | 3.43 | 17,237 | 59,123 | 360,877 | Dec 26 07:39 PM | Palantir Technologies Inc. | 10% Owner | Dec 09 '24 | Buy | 4.45 | 446,830 | 1,989,823 | 3,176,996 | Dec 11 08:12 PM |
|
|
 |
 |
Market Cap | 47.49B | EPS (ttm) | 0.43 |
P/E | 35.23 | EPS this Y | -1.77% |
Forward P/E | 29.10 | EPS next Y | 77.61% |
PEG | 1.26 | EPS past 5Y | -12.87% |
P/S | 1.57 | EPS next 5Y | 27.87% |
P/B | 1.01 | EPS Q/Q | -78.80% |
Dividend | 4.33% | Sales Q/Q | -0.06% |
Insider Own | 0.02% | Inst Own | 5.04% |
Insider Trans | 0.00% | Inst Trans | -0.88% |
Short Float | 0.14% | Earnings | Jan 30/a |
Analyst Recom | 1.88 | Target Price | 16.81 |
Avg Volume | 1.75M | 52W Range | 12.57 - 15.31 |
|
|
Apr-02-25 | Upgrade |
Morgan Stanley |
Equal-Weight → Overweight |
|
|
|
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Giles Richard Platford | President, Plasma-Derived Ther | Aug 23 '24 | Proposed Sale | 14.94 | 19,073 | 284,951 | | Aug 22 08:36 PM |
|
|
|